Pharmaceuticals
with a difference

Our range of innovative products

Learn more about our range of products

NovaTears®

View product

Maxigesic®

View product

DiaRelieve®

View product

Coco-Scalp®

View product

Crystaderm®

View product

World Map

Browse our products

Please select your region below to view products

Our Initiatives

Kiwis Thinking About Health

Kiwis Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help New Zealanders live a healthier life.

Kiwis Thinking About Health

Read More
Kiwis Thinking About Health
Our Initiatives

Aussies Thinking About Health

Aussies Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help Australians live a healthier life. 

Aussies Thinking About Health

Read More
Aussiess Thinking About Health

Maxigesic® Oral Liquid gets first regulatory approval

Maxigesic Oral Liquid – a non-opioid analgesic developed for children – achieves first approval in Europe to set up the first global launch and a pathway for further registrations and launches.

Read More

AFT at APP 2021

AFT Pharmaceuticals participate in the Australian Pharmacy Professional (APP) Conference and Trade Exhibition in May 2021.

Read More

AFT extends Maxigesic® IV license in South America

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces it has licensed Maxigesic IV into Colombia, Peru, Chile, Ecuador, Bolivia, and Uruguay, extending the medicine’s addressable market in Latin America and the Caribbean to 17 countries.

Read More